Product image of Metilprednisolone Eg (Methylprednisolone) supplied by GNH India

Metilprednisolone Eg

Active Ingredient:
Methylprednisolone
Origin:
EU

Metilprednisolone Eg (Methylprednisolone)

Methylprednisolone, the active ingredient in Metilprednisolone Eg, is a synthetic glucocorticoid presented as an oral formulation for oral administration. It exerts potent anti‑inflammatory and immunosuppressive actions and is used to manage allergic reactions, asthma, rheumatoid arthritis, skin inflammation and other systemic inflammatory disorders.

GNH India supplies Metilprednisolone Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution channels that meet EU quality standards. The company ensures reliable access for patients across multiple regions through regulated logistics and compliance monitoring.

Manufacturer / TM Owner

Eg S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Methylprednisolone acts on inflammatory and immune pathways, making it useful for several clinical conditions.
  • Allergic reactions: reduces swelling, itching and hives.
  • Asthma and other respiratory inflammatory conditions: improves airway inflammation and reduces exacerbations.
  • Rheumatoid arthritis and other autoimmune diseases: decreases joint inflammation and pain.
  • Dermatologic inflammatory disorders: alleviates severe eczema and psoriasis flares.
  • Systemic inflammatory conditions: controls widespread inflammation such as in systemic lupus erythematosus.

How It Works

  • Methylprednisolone is a synthetic glucocorticoid that diffuses across cell membranes and binds intracellular glucocorticoid receptors. The receptor complex translocates to the nucleus, where it binds glucocorticoid response elements and modulates transcription of numerous genes. This results in decreased production of pro‑inflammatory cytokines, inhibition of leukocyte migration, and suppression of immune cell activation, producing anti‑inflammatory and immunosuppressive effects.

Side Effects

Methylprednisolone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Increased appetite
  • Weight gain
  • Elevated blood glucose
  • Insomnia
  • Mood changes
  • Mild gastrointestinal discomfort

Serious or Rare Side Effects

  • Severe infections
  • Osteoporosis and fractures
  • Adrenal suppression
  • Cushingoid appearance
  • Psychosis or severe mood disorders
  • Thromboembolic events

Precautions & Warnings

  • When prescribing methylprednisolone, several safety considerations should be observed.
  • Assess infection risk: evaluate for active or latent infections before initiating therapy.
  • Monitor blood glucose: patients with diabetes may require dose adjustments.
  • Screen for osteoporosis: consider calcium and vitamin D supplementation in long‑term use.
  • Observe for adrenal insufficiency: taper gradually to avoid withdrawal.
  • Avoid in uncontrolled hypertension: monitor blood pressure regularly.
  • Store at ambient temperature: keep in original container, protect from moisture and heat.

Avoid Interactions

Methylprednisolone can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase glucocorticoid levels and toxicity.
  • Live vaccines: immunosuppression can reduce vaccine efficacy and increase infection risk.
  • Anticoagulants (warfarin): enhanced anticoagulant effect, risk of bleeding.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive risk of gastrointestinal ulceration.
  • Diuretics: may potentiate hypokalemia.
  • Antidiabetic agents: glucocorticoid‑induced hyperglycemia may require dose adjustment.

Frequently Asked Questions

Metilprednisolone Eg contains methylprednisolone, a glucocorticoid used to treat a range of inflammatory and immune‑mediated conditions such as allergic reactions, asthma, rheumatoid arthritis, severe skin disorders and other systemic inflammatory diseases.

Methylprednisolone binds to intracellular glucocorticoid receptors, forming a complex that moves into the cell nucleus and alters gene transcription. This suppresses the production of pro‑inflammatory cytokines and reduces immune‑cell activity, providing anti‑inflammatory and immunosuppressive effects.

The dose of Metilprednisolone Eg is individualized by the prescribing clinician based on the specific condition, severity, patient weight, age and response to therapy. Only a qualified healthcare professional should determine the appropriate regimen.

The pregnancy safety category for methylprednisolone is not clearly defined. It should be used during pregnancy or lactation only if the potential benefit justifies the potential risk to the fetus or infant, and after discussion with a healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Methylprednisolone is a medium‑to‑high potency glucocorticoid with a relatively rapid onset of action. Compared with prednisone, it often provides stronger anti‑inflammatory effects at equivalent doses, while having a similar safety profile when used appropriately.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture, direct sunlight and excessive heat to maintain potency.

Metilprednisolone Eg is taken orally. Swallow the tablet or capsule whole with a glass of water; it may be taken with or without food according to the prescriber’s advice.

Serious risks include severe infections, adrenal suppression, osteoporosis leading to fractures, marked hyperglycemia, Cushingoid changes, and rare psychiatric effects such as psychosis. Patients should be monitored regularly for these complications.

Individuals with known hypersensitivity to methylprednisolone or any component of the formulation, those with active systemic fungal infections, uncontrolled bacterial infections, or untreated tuberculosis should avoid this medication unless a physician determines it is essential.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylprednisolone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT